Drug recall · June 17, 2020
oxyTOCIN 30 Units/500 mL recall
Why: Subpotent drug - Product did not contain drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07
- Lots / codes
Lot#: 30010515
- Quantity
- 648 bags
- Company
- QuVa Pharma, Inc., Sugar Land, TX
- Distribution
- USA Nationwide
- Initiated
- May 28, 2020 · Voluntary: Firm initiated
- Classified
- June 11, 2020
- Reported
- June 17, 2020
- Ended
- January 19, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxytocin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.